PharmaBlock Sciences (Nanjing), Inc. is a prominent provider of innovative chemical products and services across the pharmaceutical R&D process. Its primary operations comprise a selection of specially crafted frameworks and foundational units; personalized synthesis; process enhancement; production of crucial intermediates and RSMs; and FTE services. The organization was publicly listed on the Shenzhen Stock Exchange in China on November 10, 2017. Since its inception, PharmaBlock has swiftly garnered acclaim for its exceptional proficiency in the creation, synthesis, and provision of laboratory-scale foundational units.
Products & Services
Custom Synthesis Service
GMP Manufacturing
Guanfacine
Guanfacine Hydrochloride Non Sterile Bulk Drug Substance
Sites
PharmaBlock Pharmaceuticals (Zhejiang) Co., Ltd. (A subsidiary of PharmaBlock Sciences (Nanjing), Inc.)
Country
People's Republic of ChinaCity
Shaoxing, Zhejiang
Address
Jing Ju Xi Lu 118, 322008